References

  1. Brue T, Delemer B. Diagnostic et prise en charge des hyperprolactinémies-Consensus d’experts de la Société Française d’Endocrinologie. Annales d’endocrinologie. 2007; 68(1) :8-14. PubMed | Google Scholar

  2. Rene, Gagnon Sylvain, Villeneuve Helene, Laverdiere David, Rousseau Isabelle, Bordeleau Edith, Berube Michel. Spontaneous ovarian hyperstimulation syndrome and pituitary hyperplasia mimicking macroadenoma associated with primary hypothyroidism. World J Radiol. 2013; 5(1):20-4. PubMed | Google Scholar

  3. Moumen A, Meftah A, El Jadi H, Elmoussaoui S, and Belmejdoub G. An Unusual Pituitary Mass Revealing a Primary Hypothyroidism. Clin Pract. 2015; 5(1):73. PubMed | Google Scholar

  4. Ciccarelli A, Daly AF, Beckers A. The epidemiology of prolactinomas. Pituitary. 2005; 8(1):3-6. PubMed | Google Scholar

  5. Tatiana Mancini, Felipe Casanueva F, Andrea Giustina. Hyperprolactinemia and Prolactinomas. Endocrinology and Metabolism Clinics of North America. 2008; 37(1): 67-99. PubMed | Google Scholar

  6. Beckers A, Daly FA. The clinical, pathological, and genetic features of familial isolated pituitary adenomas. Eur J Endocrinol. 2007; 157(4):371-382. PubMed | Google Scholar

  7. Asa SL, Ezzat S. The pathogenesis of pituitary tumours. Nat Rev Cancer. 2002; 2(11):836-49. PubMed | Google Scholar

  8. Foord SM, Peters JR, Dieguez C, Jasani B, Hall R, Scanlon MF. Hypothyroid pituitary cells in culture: an analysis of thyrotrophin and prolactin response to dopamine (DA) and DA receptor binding. Endocrinology. 1984; 115(1):407-15. PubMed | Google Scholar

  9. Raber W, Gessl A, Nowotny P, Vierhapper H. Hyperprolactinaemia in hypoth- yroidism: clinical significance and impact of TSH normalization. Clin Endocrinol. 2003; 58(2):185-91. PubMed | Google Scholar

  10. Shelly S, Boaz M , Orbach H. Prolactin and autoimmunity. Autoimmunity Reviews. 2012; 11(6-7): A465-70. PubMed | Google Scholar